MERCEDITA FLYNN: Open Payments
NPI 1619166188 · BEEVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 10 payments from 5 companies in 2025. Trend: 2023 $658 · 2024 $345 · 2025 $191
Food & beverage: $175Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Lilly USA, LLC | 2 | $54 |
| Novo Nordisk Inc | 2 | $33 |
| Amgen Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: BREZTRI, Ozempic, ZEPBOUND, MOUNJARO, OTEZLA, JARDIANCE, FARXIGA.
Industry payments across TX — which companies pay providers there.
